ArticleMicrobial cell factories2026
Functional characterization of HMG_9 and C
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Heat-Stress Induced Apoptosis: A New Biotechnological Strategy to Enhance Ganoderic Acids Production inJournal of fungi (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundGanoderic acids (GAs) are high-value lanostane-type triterpenoids produced by Ganoderma lucidum (G. lucidum) and are responsible for its diverse pharmacological activities. Previous studies have elucidated key enzymatic steps of the mevalonate pathway leading to lanosterol formation. However, the transcriptional regulatory mechanisms controlling the extensive downstream oxidation and modification reactions required for GA biosynthesis remain poorly understood.
resultsIn this study, two transcription factors, GlHMG_9 and GlC2H2.07, were systematically identified and functionally characterized as positive regulators of GA biosynthesis. Overexpression of either transcription factor significantly increased total triterpenoid content, whereas RNAi-mediated silencing resulted in pronounced reductions in total triterpenoids and multiple individual GAs at both mycelial and primordia stages. LC–MS analysis revealed marked decreases in representative GAs upon gene silencing. Subcellular localization confirmed nuclear localization of both proteins. Transcriptome profiling demonstrated that GlHMG_9 and GlC2H2.07 coordinately regulate genes involved in the mevalonate pathway and downstream lanosterol-derived modification steps, including cytochrome P450–mediated oxidation. Notably, GlC2H2.07 influenced a broader spectrum of biosynthesis-related genes than GlHMG_9, as evidenced by a greater number of differentially expressed genes (266 vs. 157, respectively).
conclusionsThese findings establish GlHMG_9 and GlC2H2.07 as key transcriptional regulators controlling GA biosynthesis in G. lucidum. This study provides mechanistic insights into transcription factor–mediated metabolic regulation and identifies promising regulatory targets for transcription factor–guided strain optimization, thereby providing foundational knowledge for the future development of high-yield G. lucidum cell factories through further optimization and validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.